The spectrum of cardiac side-effects of cancer chemotherapy has expanded with the
development of combination, adjuvant and targeted chemotherapies. Their administration in …

Drug-induced cardiotoxicity is emerging as an important issue among cancer survivors. For
several decades, this topic was almost exclusively associated with anthracyclines, for which …

Purpose To determine whether cardiovascular abnormalities in childhood cancer survivors
are restricted to patients exposed to cardiotoxic anthracyclines and cardiac irradiation and …

Background: The aim of this study was to assess the value of N-terminal pro-brain natriuretic
peptide (NT-proBNP) in predicting late cardiotoxicity in patients treated with not-high-dose …

The use of anthracyclines is limited by dose-dependent cardiotoxicity. Three forms of
anthracycline cardiotoxicity are described; an immediate pericarditis–myocarditis syndrome …

Multi-modality cancer treatments that include chemotherapy, radiation therapy, and targeted
agents are highly effective therapies. Their use, especially in combination, is limited by the …

(1) Background: Doxorubicin (DOX) is extensively used for cancer treatments; however, its
clinical application is limited because of its cardiotoxic adverse effects. A combination of …

Lethal cardiac complications leading to death and various arrhythmias have been reported
after organophosphate and/or carbamate poisonings. The present study focuses on the long …

The tumor microenvironment (TME) is composed of cancerous, non-cancerous, stromal, and
immune cells that are surrounded by the components of the extracellular matrix (ECM) …

Advances in cancer screening and improved treatment approaches have led to an increase
in survivorship and, consequently, recognition of an association between cancer treatments …